Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 02, 2018

SELL
$46.49 - $60.51 $1.17 Million - $1.53 Million
-25,243 Reduced 70.14%
10,745 $565,000
Q3 2017

Nov 06, 2017

SELL
$37.05 - $47.12 $926,398 - $1.18 Million
-25,004 Reduced 41.0%
35,988 $1.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
60,992
60,992 $2.16 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.1B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Redmond Asset Management, LLC Portfolio

Follow Redmond Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmond Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmond Asset Management, LLC with notifications on news.